These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15364180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
    Nilsson PM.
    Lakartidningen; 2004 Jul 22; 101(30-31):2426-7. PubMed ID: 15314941
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 9. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May 04; 148(18):42-3. PubMed ID: 16736689
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr 01; 146(14):45. PubMed ID: 15344757
    [No Abstract] [Full Text] [Related]

  • 12. Fetal toxic effects and angiotensin-II-receptor antagonists.
    Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Gubler MC.
    Lancet; 2001 Jul 21; 358(9277):241-2. PubMed ID: 11480433
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin-II-receptor inhibitors in pregnancy.
    Chung NA, Lip GY, Beevers M, Beevers DG.
    Lancet; 2001 May 19; 357(9268):1620-1. PubMed ID: 11386316
    [No Abstract] [Full Text] [Related]

  • 14. [Acute renal failure and hypertension].
    Bellido D, Sánchez de la Nieta MD, Vozmediano C, Oteros R, Zarca MA, Nieto J, Rivera F.
    Nefrologia; 2005 May 19; 25(5):563-7. PubMed ID: 16392308
    [Abstract] [Full Text] [Related]

  • 15. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N, Popovic I, Madelenat P, Mahieu-Caputo D.
    Gynecol Obstet Fertil; 2007 Jun 19; 35(6):556-60. PubMed ID: 17544313
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Second study on valsartan is threatened with retraction over alleged data manipulation.
    Mahony C.
    BMJ; 2013 Aug 05; 347():f4920. PubMed ID: 23918698
    [No Abstract] [Full Text] [Related]

  • 18. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep 21; 148(38):17. PubMed ID: 17036956
    [No Abstract] [Full Text] [Related]

  • 19. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
    Unger T.
    Fortschr Med; 1997 Aug 30; 115(24):42-3. PubMed ID: 9410822
    [No Abstract] [Full Text] [Related]

  • 20. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov 30; 45():2626-8, 2630-3. PubMed ID: 10587770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.